Rupatadine
Second generation H1-antihistamine / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Rupatadine?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Rupatadine is a second generation antihistamine and platelet-activating factor antagonist used to treat allergies. It was discovered and developed by Uriach [es][3] and is marketed as Rupafin and under several other trade names.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Rupafin, others |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 98–99% |
Metabolism | Liver, CYP-mediated |
Elimination half-life | 5.9 hours |
Excretion | 34.6% urine, 60.9% faeces |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.260.389 |
Chemical and physical data | |
Formula | C26H26ClN3 |
Molar mass | 415.97 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close